Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by malibukion Oct 14, 2017 12:13pm

92 Views

Post# 26813652

RE:RE:RE:RE:AGM overdue?!?

Sedar gives the following dates, Does it mean that people holding on 07 Nov can vote? Some frusturated holders may vote and sell before Agm then, if I do not miss something. We are approaching to a real deadline, they do not have any chance to blabla anymore, it is a binary event now. Record Date for Notice of Meeting : November 07, 2017 Record Date for Voting (if applicable) : November 07, 2017 Beneficial Ownership Determination Date : November 07, 2017 Meeting Date : December 18, 2017 Meeting Location (if available) : Vancouver, BC Issuer sending proxy related materials directly to NOBO: Yes Issuer paying for delivery to OBO: No

Bullboard Posts

Mid-year update: Charting GameSquare’s sharp business growth